Advisor Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Advisor Group’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$40K	Hold	446	–	–	﹤0.01%	3561
2019 Q3	$38K	Hold	446	–	–	﹤0.01%	3578
2019 Q2	$47K	Sell	446 -210	-32%	-$22.5K	﹤0.01%	3409
2019 Q1	$82K	Buy	656 +106	+19%	+$13.2K	﹤0.01%	3022
2018 Q4	$62K	Sell	550 -51	-8%	-$7.89K	﹤0.01%	3039
2018 Q3	$128K	Buy	601 +101	+20%	+$25.3K	﹤0.01%	2566
2018 Q2	$140K	Sell	500 -500	-50%	-$87.8K	﹤0.01%	2245
2018 Q1	$117K	Buy	1,000 +800	+400%	+$98.8K	﹤0.01%	2440
2017 Q4	$18K	Buy	+200	New	+$11.4K	﹤0.01%	3775
2016 Q4	–	Sell	-228	Closed	-$3K	–	4575
2016 Q3	$3K	Sell	228 -1	-0.4%	-$10	﹤0.01%	4074
2016 Q2	$2K	Buy	+229	New	+$2.75K	﹤0.01%	4106

Other funds holding MDGL

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Advisor Group's MDGL Position: Q4 2019 in Review

Advisor Group held its Madrigal Pharmaceuticals (MDGL) position steady in Q4 2019 at 446 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #3561.

Advisor Group first reported a position in MDGL in Q2 2016 and has held it in 11 quarters since. The position peaked at $140K in Q2 2018. 120 funds tracked by Wall St. Rank hold MDGL as of Q4 2019.

Advisor Group held 446 shares of Madrigal Pharmaceuticals worth $40K as of Q4 2019.
Advisor Group left its Madrigal Pharmaceuticals share count unchanged in Q4 2019.
Madrigal Pharmaceuticals made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3561 holding.
Advisor Group first reported a position in Madrigal Pharmaceuticals in Q2 2016 and has held it in 11 quarters since.
Advisor Group's Madrigal Pharmaceuticals position peaked at $140K in Q2 2018.
120 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.